COVID-19

Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update

Heavily pre-treated breast cancer patient who achieved stable disease on study, remains on treatment for more than eleven months after…

2 years ago

A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox

NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides SHELTON, CT / ACCESSWIRE…

2 years ago

NHI Files Supplemental Proxy

MURFREESBORO, TN / ACCESSWIRE / May 7, 2024 / National Health Investors, Inc. (NYSE:NHI) filed a proxy statement supplement (the…

2 years ago

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that…

2 years ago

Selectis Health Enters Definitive Purchase and Sale Agreement for Archway Transitional Care Center in Georgia

- Archway Nursing Facility and Related Property to be Sold for $6.75 Million - Greenwood Village, Colorado, May 09, 2024…

2 years ago

Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care

Following Nuvo’s NASDAQ Listing, Addition of Machado Brings Strong Health and Impact Experience to Remote Pregnancy Monitoring PioneerTEL AVIV, Israel,…

2 years ago

ORYZON to Provide Corporate Progress Updates at Several Events in May

Bio-Equity Europe 2024Asebio Investor Day 2024RSC Hot Topics: Covalent Drug DiscoveryForo Medcap BME 2024 MADRID, Spain and CAMBRIDGE, Mass., May…

2 years ago

NervGen Files Management Information Circular and Announces Board of Directors Transition

Bill Radvak to transition to Board Advisor following decision to not stand for re-election to NervGen's Board of DirectorsAnnual General…

2 years ago

Palisade Bio Appoints Margery Fischbein to its Board of Directors

Palisade Bio, Inc. Margery Fischbein Wall Street and biotech industry veteran with expertise across corporate finance, business development, M&A, licensing,…

2 years ago

Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.

The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity…

2 years ago